Minehiko Inomata

682 total citations
54 papers, 457 citations indexed

About

Minehiko Inomata is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Epidemiology. According to data from OpenAlex, Minehiko Inomata has authored 54 papers receiving a total of 457 indexed citations (citations by other indexed papers that have themselves been cited), including 35 papers in Oncology, 27 papers in Pulmonary and Respiratory Medicine and 8 papers in Epidemiology. Recurrent topics in Minehiko Inomata's work include Lung Cancer Treatments and Mutations (18 papers), Lung Cancer Research Studies (14 papers) and Cancer Immunotherapy and Biomarkers (11 papers). Minehiko Inomata is often cited by papers focused on Lung Cancer Treatments and Mutations (18 papers), Lung Cancer Research Studies (14 papers) and Cancer Immunotherapy and Biomarkers (11 papers). Minehiko Inomata collaborates with scholars based in Japan and United States. Minehiko Inomata's co-authors include Ryuji Hayashi, Seisuke Okazawa, Kazuyuki Tobe, Kenta Kambara, Toshiro Miwa, Shoko Matsui, Shingo Imanishi, Kensuke Suzuki, Tatsuhiko Kashii and Tomomi Ichikawa and has published in prestigious journals such as Scientific Reports, Journal of Allergy and Clinical Immunology and Cancers.

In The Last Decade

Minehiko Inomata

47 papers receiving 451 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Minehiko Inomata Japan 14 212 170 91 84 67 54 457
Kenta Kambara Japan 13 165 0.8× 160 0.9× 107 1.2× 70 0.8× 74 1.1× 35 448
Toshiro Miwa Japan 11 163 0.8× 123 0.7× 67 0.7× 64 0.8× 57 0.9× 43 362
Shinichi Yamauchi Japan 12 281 1.3× 124 0.7× 77 0.8× 118 1.4× 37 0.6× 75 540
Hiroo Imai Japan 12 165 0.8× 94 0.6× 46 0.5× 110 1.3× 39 0.6× 45 385
Xianling Liu China 10 175 0.8× 62 0.4× 65 0.7× 148 1.8× 94 1.4× 33 506
Tianrui Kuang China 10 194 0.9× 68 0.4× 53 0.6× 107 1.3× 70 1.0× 28 360
Kazuo To Japan 9 87 0.4× 74 0.4× 94 1.0× 63 0.8× 68 1.0× 16 329
Shinji Ohtake Japan 10 112 0.5× 84 0.5× 48 0.5× 82 1.0× 22 0.3× 29 292
Nancy G. Casanova United States 14 45 0.2× 269 1.6× 132 1.5× 151 1.8× 152 2.3× 28 516
Jayan George United Kingdom 6 83 0.4× 39 0.2× 125 1.4× 81 1.0× 22 0.3× 24 338

Countries citing papers authored by Minehiko Inomata

Since Specialization
Citations

This map shows the geographic impact of Minehiko Inomata's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Minehiko Inomata with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Minehiko Inomata more than expected).

Fields of papers citing papers by Minehiko Inomata

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Minehiko Inomata. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Minehiko Inomata. The network helps show where Minehiko Inomata may publish in the future.

Co-authorship network of co-authors of Minehiko Inomata

This figure shows the co-authorship network connecting the top 25 collaborators of Minehiko Inomata. A scholar is included among the top collaborators of Minehiko Inomata based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Minehiko Inomata. Minehiko Inomata is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Inomata, Minehiko, Daisuke Furukawa, Naoki Takata, et al.. (2025). A Case of EGFR-mutant Squamous Cell Lung Cancer Treated With Necitumumab Combination Therapy. In Vivo. 39(2). 1207–1210. 1 indexed citations
2.
Inomata, Minehiko, Tomomi Ichikawa, Naoki Takata, et al.. (2025). Multicenter Retrospective Analysis of Pulmonary Sarcomatoid Carcinoma Clinically Diagnosed Using Small Biopsy Specimens. Cancer Diagnosis & Prognosis. 5(3). 363–369.
3.
Inomata, Minehiko, Yosuke Kawashima, Ryota Saito, et al.. (2024). Comparing the Effectiveness of Afatinib and Osimertinib for Patients With PD-L1-positive EGFR-mutant Non-small Cell Carcinoma. Cancer Diagnosis & Prognosis. 4(4). 515–520.
4.
Inomata, Minehiko, Naoki Takata, Seisuke Okazawa, et al.. (2023). Peripheral CD4 memory T cells predict the efficacy of immune checkpoint inhibitor therapy in patients with non-small cell lung cancer. Scientific Reports. 13(1). 10807–10807. 10 indexed citations
5.
Kaneda, Makito, Kentaro Nagaoka, Hitoshi Kawasuji, et al.. (2023). Pulmonary abscess caused by Cladosporium cladosporioides after receiving outpatient chemotherapy. Journal of Infection and Chemotherapy. 29(10). 993–996. 2 indexed citations
6.
7.
Inomata, Minehiko, Naoki Takata, Seisuke Okazawa, et al.. (2021). Case Series of Pleomorphic Carcinoma of the Lung Treated With Immune Checkpoint Inhibitors. In Vivo. 35(3). 1687–1692. 5 indexed citations
8.
Takata, Naoki, Seisuke Okazawa, Kenta Kambara, et al.. (2020). Irinotecan monotherapy as third- or further-line treatment for patients with small cell lung cancer. Tumori Journal. 107(6). 536–541. 2 indexed citations
9.
Inomata, Minehiko, Naoki Takata, Seisuke Okazawa, et al.. (2020). Association of Tumor PD-L1 Expression with the T790M Mutation and Progression-Free Survival in Patients with EGFR-Mutant Non-Small Cell Lung Cancer Receiving EGFR-TKI Therapy. Diagnostics. 10(12). 1006–1006. 13 indexed citations
10.
Inomata, Minehiko, Seisuke Okazawa, Shingo Imanishi, et al.. (2019). Peripheral PD1-positive CD4 T-Lymphocyte Count Can Predict Progression-free Survival in Patients With Non-small Cell Lung Cancer Receiving Immune Checkpoint Inhibitor. Anticancer Research. 39(12). 6887–6893. 26 indexed citations
11.
Inomata, Minehiko, Seisuke Okazawa, Kenta Kambara, et al.. (2018). Clinical Parameters for Predicting the Survival in Patients with Squamous and Non-squamous-cell NSCLC Receiving PD-1 Inhibitor Therapy. Pathology & Oncology Research. 26(1). 327–333. 18 indexed citations
12.
Inomata, Minehiko, Hiroaki Tanaka, Seisuke Okazawa, et al.. (2017). Clinical Course After Initiation of Nivolumab Therapy in Patients with EGFR-Mutated Non-Small Cell Lung Cancer With or Without Pd-L1 Expression. Oncology and Therapy. 5(2). 181–185. 1 indexed citations
13.
Hayashi, Ryuji, Seisuke Okazawa, Kenta Kambara, et al.. (2017). SIRT1 and FOXO1 mRNA expression in PBMC correlates to physical activity in COPD patients. International Journal of COPD. Volume 12. 3237–3244. 19 indexed citations
14.
Suzuki, Kensuke, Kenta Kambara, Minehiko Inomata, et al.. (2017). Relationship between Carnitine Pharmacokinetics and Fatigue in Patients Treated with Cisplatin-Containing Chemotherapy. Oncology Research and Treatment. 40(1-2). 42–45. 4 indexed citations
15.
Inomata, Minehiko, Ryuji Hayashi, Seisuke Okazawa, et al.. (2015). Plasma neuron-specific enolase level as a prognostic marker in patients with non-small cell lung cancer receiving gefitinib. Molecular and Clinical Oncology. 3(4). 802–806. 12 indexed citations
16.
Suzuki, Kensuke, et al.. (2014). Thymoma with Autoimmune Hemolytic Anemia. Case Reports in Oncology. 7(3). 764–768. 6 indexed citations
17.
Suzuki, Kensuke, Tomomi Ichikawa, Seisuke Okazawa, et al.. (2014). Relationship of the urine cortisol level with the performance status of patients with lung cancer: a retrospective study. Supportive Care in Cancer. 23(7). 2129–2133. 3 indexed citations
18.
Inomata, Minehiko, Ryuji Hayashi, Seisuke Okazawa, et al.. (2014). Usefulness of the Palliative Prognostic Index in patients with lung cancer. Medical Oncology. 31(9). 154–154. 8 indexed citations
19.
Ichikawa, Tomomi, Ryuji Hayashi, Kensuke Suzuki, et al.. (2012). Sirtuin 1 activator SRT1720 suppresses inflammation in an ovalbumin‐induced mouse model of asthma. Respirology. 18(2). 332–339. 71 indexed citations
20.
Inomata, Minehiko, Yukio Kawagishi, Kenta Kambara, et al.. (2011). Visceral adipose tissue level, as estimated by the bioimpedance analysis method, is associated with impaired lung function. Journal of Diabetes Investigation. 3(3). 331–336. 14 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Kenta Kambara Breakdown of academic impact, for papers by Toshiro Miwa Breakdown of academic impact, for papers by Shinichi Yamauchi Breakdown of academic impact, for papers by Hiroo Imai Breakdown of academic impact, for papers by Xianling Liu Breakdown of academic impact, for papers by Tianrui Kuang Breakdown of academic impact, for papers by Kazuo To Breakdown of academic impact, for papers by Shinji Ohtake Breakdown of academic impact, for papers by Nancy G. Casanova Breakdown of academic impact, for papers by Jayan George
Rankless by CCL
2026